Since SRSF1 is also oncogenic in BC [15], it is conceivable that part of the NEK2 role in TNBC involves the modulation of the functional interaction between RBFOX2 and SRSF1 and consequent genome-wide transcriptome changes. Here, RBFOX2 is linked to breast cancer.